<DOC>
	<DOC>NCT00277056</DOC>
	<brief_summary>Dysregulated Tyrosine Kinase Signaling in Leukemia</brief_summary>
	<brief_title>Dysregulated Tyrosine Kinase Signaling in Leukemia</brief_title>
	<detailed_description>Purpose: to look at a number of proteins in the abnormal cells in the blood and/or bone marrow. These proteins make a cell grow or prevent the cell from dying</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<criteria>Patients must have newly diagnosed or relapsed leukemia. Patients must sign an informed consent. Patients will not be excluded if they are receiving chemotherapy. Patients with CML, AML, ALL, T/NK leukemia, myelodysplasia, or myeloproliferative disorders will be eligible. Patients must be =&gt; 18 years of age.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>leukemia</keyword>
</DOC>